Evidence map›Paper›PMID 35846748›Full record

ArticleFrontiers in cellular and infection microbiology2022

Development of Immunological Assays Based on

Sarfaraz Ahmad Ejazi, Samiran Saha, Anirban Bhattacharyya, Sonali Das, Nathália Lopes Fontoura Mateus, Manoel Sebastião da Costa Lima, Herintha Coeto Neitzke-Abreu, Ivete Lopes de Mendonca, Carlos Henrique Nery Costa, Otoni Alves de Oliveira Melo and 5 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 3 countries.

Sarfaraz Ahmad EjaziCSIR-Indian Institute of Chemical Biology, Kolkata, India.
Samiran SahaCSIR-Indian Institute of Chemical Biology, Kolkata, India.
Anirban BhattacharyyaCSIR-Indian Institute of Chemical Biology, Kolkata, India.
Sonali DasCSIR-Indian Institute of Chemical Biology, Kolkata, India.
Nathália Lopes Fontoura MateusFaculty of Veterinary Medicine and Animal Science, Universidade Federal de Mato Grosso do Sul (UFMS), Campo Grande, Brazil.
Manoel Sebastião da Costa LimaAggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife, Pernambuco, Brazil.
Herintha Coeto Neitzke-AbreuFaculty of Health Sciences, Universidade Federal da Grande Dourados (UFGD), Mato Grosso do Sul, Brazil.
Ivete Lopes de MendoncaDepartamento de Clínica e Cirurgia Veterinária, Universidade Federal do Piaui (UFPI), Teresina, Brazil.
Carlos Henrique Nery CostaDepartamento de Clínica e Cirurgia Veterinária, Universidade Federal do Piaui (UFPI), Teresina, Brazil.
Otoni Alves de Oliveira MeloInstituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Marcia Almeida de MeloPrograma de Pós-Graduação em Ciência e Saude Animal, Universidade Federal de Campina Grande (UFCG), Campina Grande, Brazil.
Bartira Rossi-BergmannInstituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Raffaele CorsoPrevention Department, Distretto Sanitario 12, Unità Operativa di Prevenzione Collettiva, Azienda Sanitaria Locale Caserta, Caserta, Italy.
Laura MannaDepartment of Veterinary Medicine and Animal Production, University of Naples, Federico II, Naples, Italy.
Nahid AliCSIR-Indian Institute of Chemical Biology, Kolkata, India.
Indian Institute of Chemical Biology · INUniversidade Federal do Piauí · BRUniversidade Federal do Rio de Janeiro · BRASL Roma · ITFundação Oswaldo Cruz · BRUniversidade Federal da Grande Dourados · BRUniversidade Federal de Campina Grande · BRUniversidade Federal de Mato Grosso do Sul · BRUniversity of Naples Federico II · IT

Funding

Medical Research Council MR/P027989/1
6 · The paper itself

Abstract

Canine visceral leishmaniasis (CVL) due to

Indexed as

Dog DiseasesLeishmania donovaniLeishmania infantumLeishmaniasis, VisceralAnimalsAntibodies, ProtozoanAntigens, ProtozoanBrazilDogsEnzyme-Linked Immunosorbent AssayHumansSensitivity and SpecificityAntibodies, ProtozoanAntigens, Protozoancaninediagnosisimmunochromatographyic test (ICT)Leishmaniaserology

Identifiers

PMID35846748
PMCPMC9283983
OpenAlexW4283739614

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.